PUBLISHER: The Business Research Company | PRODUCT CODE: 1877861
PUBLISHER: The Business Research Company | PRODUCT CODE: 1877861
A real-time blood glucose continuous glucose monitoring (CGM) patch refer to a wearable medical device that continuously measures glucose levels in the interstitial fluid beneath the skin, providing real-time data. It helps individuals with diabetes track blood sugar trends, identify fluctuations, and make timely adjustments to insulin or diet for improved glycemic control. These patches minimize the need for frequent finger-prick tests while supporting proactive glucose management.
The key product types of real-time blood continuous glucose monitoring (CGM) patches include wearable continuous glucose monitoring patches and implantable continuous glucose monitoring patches. A wearable continuous glucose monitoring patch is a digital health device that continuously monitors glucose levels in real time via a sensor applied to the skin, aiding diabetes management, improving glycemic control, and supporting personalized treatment decisions. These patches use technologies such as enzymatic and non-enzymatic sensors and are applied across diabetes conditions including type 1 diabetes, type 2 diabetes, gestational diabetes, and others. They are distributed through channels such as online pharmacies, retail pharmacies, and hospital pharmacies, serving end users including hospitals, clinics, homecare settings, diagnostic centers, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.
The real-time blood glucose continuous glucose monitoring (CGM) patch market research report is one of a series of new reports from The Business Research Company that provides real-time blood glucose continuous glucose monitoring (CGM) patch market statistics, including real-time blood glucose continuous glucose monitoring (CGM) patch industry global market size, regional shares, competitors with a real-time blood glucose continuous glucose monitoring (CGM) patch market share, detailed real-time blood glucose continuous glucose monitoring (CGM) patch market segments, market trends and opportunities, and any further data you may need to thrive in the real-time blood glucose continuous glucose monitoring (CGM) patch industry. This real-time blood glucose continuous glucose monitoring (CGM) patch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The real-time blood glucose continuous glucose monitoring (cgm) patch market size has grown rapidly in recent years. It will grow from $6.41 billion in 2024 to $7.05 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth during the historical period can be attributed to the rising prevalence of diabetes, greater adoption of wearable healthcare devices, increasing demand for minimally invasive glucose monitoring solutions, and growing awareness of diabetes management and self-monitoring.
The real-time blood glucose continuous glucose monitoring (CGM) patch market size is expected to see rapid growth in the next few years. It will grow to $10.47 billion in 2029 at a compound annual growth rate (CAGR) of 10.4%. The growth during the forecast period is driven by the rising demand for remote patient monitoring and telehealth solutions, increasing consumer interest in personalized healthcare solutions, growing preference for home-based healthcare monitoring, increasing focus on preventive healthcare and early intervention, and rising awareness of the advantages of continuous glucose monitoring over traditional methods. Primary trends in the forecast period include the development of personalized diabetes management platforms, integration with telemedicine systems for remote patient monitoring, integration with fitness trackers for comprehensive health insights, innovation in bio-compatible materials for longer wear and skin comfort, and integration with electronic health records for seamless clinician monitoring.
The rising adoption of remote monitoring and telehealth is expected to enhance the growth of the real time blood glucose CGM patch market in the coming years. Remote monitoring refers to the use of digital technologies to collect and transmit a patient's health data, such as blood glucose levels, heart rate, or blood pressure, from outside traditional clinical settings to healthcare providers for continuous assessment and management. Telehealth adoption involves the growing use of virtual healthcare services, including video consultations, remote follow ups, and digital communication between patients and healthcare providers. The adoption of remote monitoring and telehealth is increasing due to rising demand for convenient and accessible healthcare services, particularly for managing chronic conditions such as diabetes. Real time blood glucose CGM patches support this trend by enabling continuous, real time data sharing with healthcare providers, allowing timely interventions and effective virtual diabetes management. For example, in February 2025, according to the American Hospital Association, a U.S. based national organization, the United States is expected to face a shortage of up to 86,000 physicians by 2036, emphasizing the crucial role of telehealth in addressing this healthcare gap. Therefore, the rising adoption of remote monitoring and telehealth is enhancing the growth of the real time blood glucose CGM patch market.
Prominent players operating in the real-time blood glucose continuous glucose monitoring (CGM) patch market are emphasizing the development of advanced products, such as water-resistant sensors, to improve user convenience and ensure reliable continuous monitoring. A water-resistant sensor is an advanced device engineered to operate accurately and consistently even when exposed to water or perspiration, safeguarding its internal components from potential damage. For example, in February 2024, Dexcom Inc., a United States-based medical device manufacturer, introduced the Dexcom ONE+, a real-time continuous glucose monitoring system in Spain, Belgium, and Poland. The system delivers a compact, highly accurate, and user-friendly CGM solution that provides real-time glucose readings around the clock with customizable alerts, including a unique delay-first high notification to minimize alarm fatigue. It features an integrated water-resistant sensor compatible with multiple wear locations, a fast 30-minute warm-up period, a 10-day sensor life with a 12-hour grace window for replacement, and seamless connectivity to smartphones and receivers, facilitating effective and continuous diabetes management.
In April 2025, Cardinal Health Incorporated, a US-based healthcare company, acquired Advanced Diabetes Supply Group (ADSG) for an undisclosed amount. Through this acquisition, Cardinal Health aims to expand its at-home solutions business, reach more patients with innovative diabetes care, accelerate growth within the expanding diabetes population, and enhance patient-centric care delivery. Advanced Diabetes Supply Group is a US-based medical equipment distributor that provides real-time continuous glucose monitoring (CGM) patches.
Major players operating in the real-time blood glucose continuous glucose monitoring (CGM) patch market are Abbott Laboratories (FreeStyle), Dexcom Inc., F. Hoffmann-La Roche AG, Zhejiang POCTech Co. Ltd, Medtronic PLC, Senseonics Holdings, Inc. (Eversense), MicroTech Medical Inc., A. Menarini Diagnostics, Biolinq, Metronom Health, Medtrum Technologies Inc., Afon Technology, Nemaura Medical Inc., Ultrahuman Healthcare Pvt Ltd.
North America was the largest region in the real-time blood glucose continuous glucose monitoring (CGM) patch market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the real-time blood glucose continuous glucose monitoring (CGM) patch market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the real-time blood glucose continuous glucose monitoring (CGM) patch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The real-time blood glucose continuous glucose monitoring (CGM) patch market consists of revenues earned by entities by providing services such as continuous glucose monitoring, data analysis and reporting, remote patient monitoring, device maintenance and calibration services, and clinical trial support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The real-time blood glucose continuous glucose monitoring (CGM) patch market also includes sales of long-wear continuous glucose monitoring patches, waterproof continuous glucose monitoring patches, wireless continuous glucose monitoring patches, pediatric continuous glucose monitoring patches, and multi-sensor continuous glucose monitoring patches. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Real-Time Blood Glucose CGM Patch Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on real-time blood glucose cgm patch market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for real-time blood glucose cgm patch ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The real-time blood glucose cgm patch market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.